sglt2 vs glp 1 The effect of DPP-4 inhibitors, GLP-1 receptor agonists and SGLT-2 inhibitors on cardiorenal outcomes: a network meta-analysis of 23 CVOTs | Cardiovascular Diabetology SGLT2 vs GLP-1 for CKD:

Both agents provided clinically meaningful reductions in HbA 1c (2.6 mmol/mol [0.2%] with SGLT2i and 5.4 mmol/mol [0.5%] with GLP-1 RA)

Plus, the product is $65 for a 10 day supply

Reconstituted BPC-157 stored at 28C remains stable for 28 days according to stability testing on lyophilized peptides

Hence current advice is aimed at symptom management and lifestyle changes ( Figure 12

Semaglutide was the most cost-effective treatment compared to exenatide, dulaglutide, liraglutide, or no treatment in short-term analyses (approximately one and a half years) that assessed quality-adjusted life years and incremental cost-effectiveness ratios [135,136,137,138,139,140,141,142,143,144]